LY3009104

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3009104, covering 2017-04-21 to 2017-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3009104 in Healthy Participants [Phase 1]